Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “WAGR Syndrome”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Early research (Phase 1)Study completedNCT02498665
What this trial is testing

DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesGlioblastoma Multiforme+6 more
Sumitomo Pharma America, Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT03311334
What this trial is testing

DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Urothelial CarcinomaPrimary Peritoneal Cancer+3 more
Sumitomo Pharma America, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT01827137
What this trial is testing

WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Sellas Life Sciences Group 20
Not applicableStudy completedNCT00758108
What this trial is testing

Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions

Who this might be right for
WAGR SyndromeWilm's TumorAniridia+2 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 197
Early research (Phase 1)Study completedNCT05360680
What this trial is testing

In Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

Who this might be right for
Colorectal CancerGastric CancerPancreatic Cancer+1 more
Cue Biopharma 42
Not applicableLooking for participantsNCT06740162
What this trial is testing

Physical Activity and Community EmPOWERment Project

Who this might be right for
Intellectual DisabilityNeurodevelopmental DisordersAutism Spectrum Disorder+10 more
University of North Carolina, Chapel Hill 376
Testing effectiveness (Phase 2)Study completedNCT02649829
What this trial is testing

Autologous Dendritic Cell Vaccination in Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University Hospital, Antwerp 28
Large-scale testing (Phase 3)UnknownNCT01809392
What this trial is testing

Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myelocytic LeukemiaMyelodysplastic Syndromes
The First Affiliated Hospital of Soochow University 15
Testing effectiveness (Phase 2)Looking for participantsNCT05765084
What this trial is testing

Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University Hospital, Antwerp 15
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Large-scale testing (Phase 3)Study completedNCT03149003
What this trial is testing

DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

Who this might be right for
Glioblastoma
Sumitomo Pharma America, Inc. 221